We don’t know much about Gregory T. Lucier. He is CEO of is our favorite Carlsbadistan-based life sciences company, Life Technologies. And under his guidance the company’s stock has gone up nearly $10 a share since we decided to “invest in Carlsbadistan.” And he thinks things are only going to get better for his industry.
I actually think we’re heading into the golden age of drug discovery and development. We’ve reached a point where our grasp and knowledge of these tools is finally allowing the researchers to get answers faster. So I’m hopeful the next 10 years will be different than the last 10 years of this kind of dearth of new products we saw coming out of pharmaceutical companies.
Now, thanks to the The San Diego Union-Tribune’s Thomas Kupper we know much more about the 45-year-old HBS MBA and you will too if you read this interview.
[Link: San Diego Union-Tribune]
RSS Feed-Posts
{ 0 comments… add one now }